About GlycoDesign

About company

GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment or prevention of cardiovascular and chronic inflammatory diseases, as well as cancer. It focuses on two anti-thrombotic drug candidates, GH9001 and ATH, as well as in the development of glycotherapeutics for the potential treatment of chronic inflammation and cancer.